Legal Representation
Attorney
Peter M. Klobuchar
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 1, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 1, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 12, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 10, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 10, 2014 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 10, 2014 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 29, 2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 3, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 14, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 31, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 31, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 16, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 13, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 12, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 12, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 15, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 15, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 15, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 14, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Sep 20, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, prescription and non-prescription drugs for the treatment of musculoskeletal disorders, epilepsy, emphysema, breast cancer, infection, cardiac arrhythmia, hypertension, pain, allergies, eye infections, mastocytosis, cysts, arthritis, spondylitis, throat irritation, bronchial irritation, cough and nasal congestion, bacterial conjunctivitis, high blood pressure, conjunctivitis, corneal ulcers, inflammation, convulsions, seizures, eye pressure, Parkinson's Disease, tremors, ear infections, bipolar disorder, overactive bladder, asthma, diabetes, depression, migraine, potassium deficiency, vertigo, menopausal conditions and symptoms, edema, hypotension, actinic keratosis, endometriosis, dry mouth, Vitamin D deficiency, altitude and motion sickness, coagulation disorders, Crohn's Disease; anti viral, anti fungal and anti psychotic medications; and potassium supplements
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005